H1H2 Capital
H1H2 Capital is a venture capital firm based in Boston, United States. This profile covers what we know about H1H2 Capital and how founders can get in front of it in 2026.
H1H2 Capital is a capital investment firm that focuses on creating alternative wealth and income sources for investors.
- Location
- Boston, United States
- Team size
- 1-10
How to pitch H1H2 Capital
The founders who hear back from H1H2 Capital lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with H1H2 Capital
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "H1H2 Capital." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/h1h2-capital
Frequently Asked Questions
What is H1H2 Capital?
H1H2 Capital is a venture capital firm based in Boston, United States. Round Funded tracks its focus, stage, and activity alongside thousands of active investors.
Where is H1H2 Capital based?
H1H2 Capital is based in Boston, United States. You can reach out from anywhere with a pitch that matches its focus.
How do I contact H1H2 Capital?
Unlock a verified email for H1H2 Capital and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.